Boesen Biotech ApS: Financial statements 2025
CVR: 39142635
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600. The solvency ratio was 42.2%.
- Gross Profit
- DKK -54,998
- Profit/Loss
- DKK 2,039,886
- Equity
- DKK 3,496,600
- Total Assets
- DKK 8,288,533
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -55K | 2M | 3.5M | 0 |
| 2024 | - | -21K | 724K | 1.5M | 0 |
| 2023 | - | -28K | -4M | 733K | 0 |
| 2022 | - | -36K | -5.5M | 4.7M | - |
| 2021 | - | -34K | 8.1M | 10.2M | - |
Official annual report
How creditworthy is Boesen Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Boesen Biotech ApS has published its annual report for 2024. Gross profit came to DKK -21,066, and the net result was DKK 723,812.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.